![Meng Yao Chen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Meng Yao Chen
Directeur/Bestuurslid bij Vita Genomics, Inc.
Profiel
Meng Yao Chen is currently a Director at Vita Genomics, Inc. Prior to this, he was a Director & Deputy General Manager at Hakers Enterprise Co. Ltd.
Actieve functies van Meng Yao Chen
Bedrijven | Functie | Begin |
---|---|---|
Vita Genomics, Inc.
![]() Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan. | Directeur/Bestuurslid | 12-08-2010 |
Eerdere bekende functies van Meng Yao Chen
Bedrijven | Functie | Einde |
---|---|---|
HAKERS ENTERPRISE CO., LTD. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
HAKERS ENTERPRISE CO., LTD. | Consumer Non-Durables |
Bedrijven in privébezit | 1 |
---|---|
Vita Genomics, Inc.
![]() Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan. | Health Services |